Cytosorbents Corporation (CTSO): Price and Financial Metrics
CTSO Price/Volume Stats
| Current price | $0.86 | 52-week high | $1.61 |
| Prev. close | $0.81 | 52-week low | $0.70 |
| Day low | $0.84 | Volume | 47,306 |
| Day high | $0.90 | Avg. volume | 199,706 |
| 50-day MA | $1.00 | Dividend yield | N/A |
| 200-day MA | $1.04 | Market Cap | 53.64M |
CTSO Stock Price Chart Interactive Chart >
Cytosorbents Corporation (CTSO) Company Bio
CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.
CTSO Price Returns
| 1-mo | -14.85% |
| 3-mo | -33.85% |
| 6-mo | -3.91% |
| 1-year | 2.26% |
| 3-year | -59.62% |
| 5-year | -91.68% |
| YTD | -5.49% |
| 2024 | -18.02% |
| 2023 | -28.39% |
| 2022 | -63.01% |
| 2021 | -47.43% |
| 2020 | 107.01% |
Continue Researching CTSO
Want to see what other sources are saying about Cytosorbents Corp's financials and stock price? Try the links below:Cytosorbents Corp (CTSO) Stock Price | Nasdaq
Cytosorbents Corp (CTSO) Stock Quote, History and News - Yahoo Finance
Cytosorbents Corp (CTSO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...